PIMG
XBI icon

Patriot Investment Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Patriot Investment Management Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
6,812
-236
-3% -$31.9K 0.06% 118
2026
Q1 		$900K Buy
7,048
+495
+8% +$61.8K 0.06% 125
2025
Q4 		$799K Buy
6,553
+41
+0.6% +$4.7K 0.05% 129
2025
Q3 		$653K Hold
6,512
– – 0.04% 144
2025
Q2 		$540K Buy
6,512
+387
+6% +$30.9K 0.04% 151
2025
Q1 		$497K Buy
6,125
+62
+1% +$5.54K 0.04% 152
2024
Q4 		$546K Sell
6,063
-375
-6% -$36.3K 0.04% 147
2024
Q3 		$636K Hold
6,438
– – 0.05% 141
2024
Q2 		$597K Sell
6,438
-375
-6% -$33.6K 0.05% 146
2024
Q1 		$646K Sell
6,813
-33
-0.5% -$3.06K 0.05% 140
2023
Q4 		$611K Buy
6,846
+600
+10% +$44.6K 0.05% 143
2023
Q3 		$456K Sell
6,246
-764
-11% -$61K 0.04% 159
2023
Q2 		$583K Buy
7,010
+214
+3% +$17.9K 0.05% 153
2023
Q1 		$518K Buy
6,796
+5
+0.1% +$415 0.05% 163
2022
Q4 		$607K Sell
6,791
-55
-0.8% -$4.45K 0.05% 151
2022
Q3 		$543K Sell
6,846
-200
-3% -$16.9K 0.06% 152
2022
Q2 		$523K Buy
7,046
+1,111
+19% +$83.4K 0.05% 158
2022
Q1 		$533K Buy
5,935
+415
+8% +$38.3K 0.05% 173
2021
Q4 		$618K Buy
5,520
+348
+7% +$42K 0.05% 158
2021
Q3 		$650K Buy
5,172
+95
+2% +$12.2K 0.06% 149
2021
Q2 		$687K Buy
5,077
+23
+0.5% +$3.02K 0.06% 143
2021
Q1 		$685K Buy
5,054
+440
+10% +$65.9K 0.07% 138
2020
Q4 		$649K Sell
4,614
-488
-10% -$62.5K 0.1% 100
2020
Q3 		$568K Hold
5,102
– – 0.07% 141
2020
Q2 		$571K Buy
5,102
+434
+9% +$42.7K 0.07% 135
2020
Q1 		$361K Buy
4,668
+1,301
+39% +$115K 0.05% 154
2019
Q4 		$320K Hold
3,367
– – 0.04% 182
2019
Q3 		$256K Sell
3,367
-737
-18% -$61.3K 0.04% 192
2019
Q2 		$359K Buy
4,104
+608
+17% +$51.9K 0.05% 167
2019
Q1 		$316K Buy
+3,496
New +$297K 0.05% 176

Other funds holding XBI

PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

Patriot Investment Management Group's XBI Position: Q2 2026 in Review

Patriot Investment Management Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3.3% in Q2 2026, selling an estimated $31.9K and leaving 6,812 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #118.

Patriot Investment Management Group first reported a position in XBI in Q1 2019 and has held it in 30 quarters since. 343 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Patriot Investment Management Group held 6,812 shares of State Street SPDR S&P Biotech ETF worth $1.08M as of Q2 2026.
  • Patriot Investment Management Group sold 236 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $31.9K.
  • State Street SPDR S&P Biotech ETF made up 0.06% of Patriot Investment Management Group's portfolio in Q2 2026, its #118 holding.
  • Patriot Investment Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 30 quarters since.
  • 343 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.